<- Go Home

Medpace Holdings, Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Market Cap

$15.4B

Volume

408.2K

Cash and Equivalents

$285.4M

EBITDA

$535.5M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$1.6B

Profit Margin

69.58%

52 Week High

$554.14

52 Week Low

$250.05

Dividend

N/A

Price / Book Value

52.45

Price / Earnings

38.18

Price / Tangible Book Value

-38.27

Enterprise Value

$15.2B

Enterprise Value / EBITDA

26.28

Operating Income

$507.0M

Return on Equity

73.70%

Return on Assets

16.52

Cash and Short Term Investments

$285.4M

Debt

$119.1M

Equity

$293.6M

Revenue

$2.4B

Unlevered FCF

$526.4M

Sector

Life Sciences Tools and Services

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches